Capitalism is key to solve disease and reduce inequality in access to drugs and healthcare.
Holmstrom & Cudd ’11 [Nancy, Professor Emerita and former Chair of Philosophy at Rutgers University, Newark; and Ann E, Provost and Senior Vice Chancellor & Professor of Philosophy at the University of Pittsburgh. 2011. “Capitalism, For and Against: A Feminist Debate.” Cambridge University Press. p. 60-61; JFan]
A common misperception in the literature on development and health outcomes is that if a positive public health outcome can now be achieved without accumulation of wealth and capital, then such development, and capitalism in particular, could not be causally responsible for improvements in health. 73 But this follows neither for the historical nor the contemporary case. I have just argued the historical case. Consider two contemporary examples of lifesaving and life improving medical advances. The development of anti-retroviral drugs to combat AIDS has been incredibly expensive, although today the drugs themselves are not expensive to make and they are being distributed in many developing countries for very low prices. These drugs are saving many lives. But clearly they would not exist at all were it not for the massive investments in capital and scientific expertise in academic settings in developed capitalist countries. Capitalism provided the wealth accumulation that made this possible, even while it was the collective action of government allocating funds for development of the drugs and global health organizations that made possible their delivery to poor, mainly noncapitalist countries. Another biomedical advance that promises to save or improve the health of many premature infants is the development of the actifier. Premature infants often have trouble learning to suckle, a task that requires a great deal of coordination of sucking, swallowing, and breathing muscles. The actifier is a simple, cheap device that provides instant feedback to the infant that teaches it to suckle properly, often in just a few sessions. Learning this coordination of muscles is the first step that infants need to take to bootstrap cognitive skills necessary for a successful and rich human life. It also allows infants to breastfeed, which is especially crucial in places where water quality is questionable and assaults against a child’s immune system are likely to be many. This device will no doubt save many lives at low cost in developing countries. But its development has required a massive investment in science – the main developer of the device has a million dollar laboratory and many postdocs who work for him. And this accounting leaves out the many mis-steps and wrong turns that less successful innovations have taken. Any one successful biomedical device or drug comes from a large number of trials and errors, most of which are costly but never recover their cost directly.